DECENTRALIZED TRIAL (DCT) TECHNOLOGY INSIGHTS
-
![planning analyzing, business plan investment, Consultant, finance analysis-GettyImages-1868740441]( "Tufts & PACT Release New DCT Analysis")
Tufts & PACT Release New DCT AnalysisWe take a closer look at some of the key stats in a new DCT report from the Partnership for Advancing Clinical Trials (PACT), a consortium hosted and facilitated by the Tufts Center for the Study of Drug Development (CSDD).
-
![Keynote crowd 2]( "Not What I Expected From A Vendor Conference")
Not What I Expected From A Vendor ConferenceDan Schell recounts some of his key takeaways after attending the Veeva R&D Quality Summit in Boston in September 2024. Some of the topics discussed include DCTs, eCOA, and the need to simplify tech integration at sites.
DCT TECHNOLOGY VIDEOS
Accelerate clinical trial modernization with streamlined collection of continuous, high-precision data centered on the patient.
Dr. Andy Liu presents a case study determining which digital measure of physical activity would be a well-defined and reliable clinical endpoint in a trial including patients with diabetes.
Dr. Jie Shen, Research Fellow and Director of Digital Science at AbbVie, shares lessons learned from incorporating digital measures of physical activity into Phase 3 immunology clinical trials.
How can wearable DHTs be leveraged to measure physical activity in patients with immunological diseases, enhancing clinical trials and advancing drug development?
DCT TECHNOLOGY RESOURCES
-
![GettyImages-1189687523 AI]( "The Pharmaceutical Industry: 2024 (And Beyond) Predictions")
DCTs, RWD, IRA … our industry predictions for 2024 are filled with acronyms. As we delve into 2024, explore what trends are hot ― and not ― for the coming year, and their impact on the industry.
-
![patient data iStock-1274428125]( "How “Future-Proof” Is Your Digital Biomarker Data?")
This white paper provides a comprehensive overview of wearable sensor data processing frameworks, traditional and emerging analytic methods, and how clinical trial sponsors will maximize their investment and ensure the long-term value of their digital biomarker data by selecting a wearable technology platform that collects and provides access to raw, “future-proof” source data.
-
![GettyImages-870849774 EDC medrio]( "Pitfalls And Possibilities: EHRs To RWD Via EDC")
Consider DIA GCP & QA Community Chair Terry Katz’s perspective on repurposing and analyzing EHR data for clinical research.
-
![gettyimages-1185375169-170667a]( "Combining Patient-Centric Technology and RWD For Comprehensive Evidence")
Explore how by combining digital technologies with secondary RWD, researchers can gather a more holistic understanding of the patient.
-
![GettyImages-1406125969 laptop idea]( "Advanced Analytics To Power Action Across The Trial Continuum")
Examine how Medidata's Clinical Operations solutions are working to improve the efficiency of study timelines through their platform, guided by interconnected workflows and data-driven insights.
-
![GettyImages-1310986619 patient]( "Collecting Trial Data From Patients In Remote Areas")
Learn how mobile technology can promote trial inclusivity and diversity, and its potential to revolutionize clinical studies, making them more accessible and representative of the population.
-
![Patient Care GettyImages-1288871608]( "Want To Make Your Trial More Patient-Centric? Here's An eCOA For That")
Electronic clinical outcome assessments transform the paper-based evaluation into a real-time digital tool that collects insights directly from the patient. Explore how this brings several immediate benefits.
